Taddese Menassie
Reporting owner on Forms 3, 4 and 5, CIK 1848805.
Taddese Menassie reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| XERS · Xeris Biopharma Holdings, Inc.CIK 1867096 | director | 1 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| XERS · Xeris Biopharma Holdings, I…Common Stock | 2026-11-02 | A granted | +22,365 | $0 | 22,365 | Form 4 |
| XERS · Xeris Biopharma Holdings, I…Stock Option (Right to Buy), derivative | 2026-11-02 | A granted | -31,499 | $10.17 | 31,499 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001867096-26-000105 | Xeris Biopharma Holdings, Inc. | 2026-11-04 | ||
| Form 3 0001867096-26-000103 | Xeris Biopharma Holdings, Inc. | 2026-11-04 |